Horsens, Denmark-based Hamlet Protein, which produces soy-based protein feed for trout, salmon, and shrimp production, is taking aim at the U.S. market.
The multinational firm, which operates a production facility and U.S. sales arm in Findlay, Ohio, has announced it is investing in its U.S. operations with the intention of growing its sales of piglet, poultry, cattle, and aquaculture feed.
Hamlet Protein opened its Findlay plant in 2012 and recently completed a major investment to increase its production capacity, Hamlet Protein CEO Erik Visser said in a press release.
“The U.S. animal feed market is expected to grow at a CAGR of 2.4 percent, from USD 75 billion [EUR ] in 2018 to USD 85 billion [EUR ] in 2024. Not only will the total feed volume grow, but the need to produce more efficiently will take center stage,” Visser, who replaced former CEO Søren Munch in June 2019, said. “Also, consumers will drive the reduction of antibiotics in feed, which is where Hamlet Protein can play a role. We are optimistic about our potential in the North American market, considering our track record in other markets around the world.”
As part of its expansion plans, Hamlet Protein announced on 12 November the hiring of Grady Fain as its new vice president sales and marketing for North America. Fain previously worked at Nutriad Inc. and Adisseo.
“Over the course of my career I have always focused on working with companies that bring true value to customers,” Fain said. “Hamlet Protein has a high-quality product portfolio with a proven track record in markets across the world.”
Photo courtesy of Hamlet Protein
